These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 17405587)

  • 1. Combined diet and exercise intervention in the workplace: effect on cardiovascular disease risk factors.
    White K; Jacques PH
    AAOHN J; 2007 Mar; 55(3):109-14. PubMed ID: 17405587
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Developing a Health-Promotion Program Based on the Action Research Paradigm to Reduce Cardiovascular Disease Risk Factors among Blue Collar Workers.
    Hwang WJ; Kim JA
    Int J Environ Res Public Health; 2019 Dec; 16(24):. PubMed ID: 31817658
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ferrari Corporate Wellness Program: Results of a Pilot Analysis and the "Drag" Impact in the Workplace.
    Biffi A; Fernando F; Adami PE; Messina M; Sirico F; Di Paolo F; Coluccia R; Borghi C; D'Ascenzi F; Volpe M
    High Blood Press Cardiovasc Prev; 2018 Sep; 25(3):261-266. PubMed ID: 29956111
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Worksite Opportunities for Wellness (WOW): effects on cardiovascular disease risk factors after 1 year.
    Racette SB; Deusinger SS; Inman CL; Burlis TL; Highstein GR; Buskirk TD; Steger-May K; Peterson LR
    Prev Med; 2009; 49(2-3):108-14. PubMed ID: 19576927
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of cardiac rehabilitation and exercise training in obese patients with coronary artery disease.
    Lavie CJ; Milani RV
    Chest; 1996 Jan; 109(1):52-6. PubMed ID: 8549217
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lipid profiles in the Isfahan population: an Isfahan cardiovascular disease risk factor survey, 1994.
    Rafiei M; Boshtam M; Sarraf-Zadegan N
    East Mediterr Health J; 1999 Jul; 5(4):766-77. PubMed ID: 11338699
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term effects of a reduced fat diet intervention on cardiovascular disease risk factors in individuals with glucose intolerance.
    Ley SJ; Metcalf PA; Scragg RK; Swinburn BA
    Diabetes Res Clin Pract; 2004 Feb; 63(2):103-12. PubMed ID: 14739050
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combined dietary and exercise intervention for control of serum cholesterol in the workplace.
    Angotti CM; Chan WT; Sample CJ; Levine MS
    Am J Health Promot; 2000; 15(1):9-16. PubMed ID: 11184120
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardiovascular results of an individually controlled complex prevention.
    Noé JG; Dósa A; Ránky M; Pavlik G
    Acta Physiol Hung; 2014 Mar; 101(1):1-12. PubMed ID: 24631792
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Prevalence of cardiovascular risk factors in coronary heart disease patients with different low-density lipoprotein phenotypes].
    Slapikas R; Luksiene D; Slapikiene B; Babarskiene MR; Grybauskiene R; Linoniene L
    Medicina (Kaunas); 2005; 41(11):925-31. PubMed ID: 16333215
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of a multicomponent workplace health promotion program conducted in Japan for improving employees' cardiovascular disease risk factors.
    Muto T; Yamauchi K
    Prev Med; 2001 Dec; 33(6):571-7. PubMed ID: 11716652
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Workplace-based cardiovascular risk management by community pharmacists: impact on blood pressure, lipid levels, and weight.
    John EJ; Vavra T; Farris K; Currie J; Doucette W; Button-Neumann B; Osterhaus M; Kumbera P; Halterman T; Bullock T
    Pharmacotherapy; 2006 Oct; 26(10):1511-7. PubMed ID: 16999661
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Consumption of a controlled low-fat diet containing olestra for 9 months improves health risk factors in conjunction with weight loss in obese men: the Ole' Study.
    Lovejoy JC; Bray GA; Lefevre M; Smith SR; Most MM; Denkins YM; Volaufova J; Rood JC; Eldridge AL; Peters JC;
    Int J Obes Relat Metab Disord; 2003 Oct; 27(10):1242-9. PubMed ID: 14513073
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Family-centered brief intervention for reducing obesity and cardiovascular disease risk: A randomized controlled trial.
    Duncan S; Goodyear-Smith F; McPhee J; Zinn C; Grøntved A; Schofield G
    Obesity (Silver Spring); 2016 Nov; 24(11):2311-2318. PubMed ID: 27616217
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Hyperlipidemia and hyperglycemia prevalence in obese children: increased risk of cardiovascular disease?].
    Marcano M; Solano L; Pontiles M
    Nutr Hosp; 2006; 21(4):474-83. PubMed ID: 16913207
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Impact of Lifestyle Modification on Cardiometabolic Risk Factors in Health-Care Employees With Type 2 Diabetes.
    Das S; Rouseff M; Guzman HE; Osondu CU; Brown D; Betancourt B; Ochoa T; Mora J; Lehn V; Sherriff SB; Rubens MB; Saxena A; Nasir K; Veledar E
    Am J Health Promot; 2019 Jun; 33(5):745-748. PubMed ID: 30651005
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aerobic exercise reduces biomarkers related to cardiovascular risk among cleaners: effects of a worksite intervention RCT.
    Korshøj M; Ravn MH; Holtermann A; Hansen ÅM; Krustrup P
    Int Arch Occup Environ Health; 2016 Feb; 89(2):239-49. PubMed ID: 26139093
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of an intervention to improve the cardiovascular health of family members of patients with coronary artery disease: a randomized trial.
    Reid RD; McDonnell LA; Riley DL; Mark AE; Mosca L; Beaton L; Papadakis S; Blanchard CM; Mochari-Greenberger H; O'Farrell P; Wells GA; Slovinec D'Angelo ME; Pipe AL
    CMAJ; 2014 Jan; 186(1):23-30. PubMed ID: 24246588
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of high vs low glycemic index of dietary carbohydrate on cardiovascular disease risk factors and insulin sensitivity: the OmniCarb randomized clinical trial.
    Sacks FM; Carey VJ; Anderson CA; Miller ER; Copeland T; Charleston J; Harshfield BJ; Laranjo N; McCarron P; Swain J; White K; Yee K; Appel LJ
    JAMA; 2014 Dec; 312(23):2531-41. PubMed ID: 25514303
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: results of AFCAPS/TexCAPS. Air Force/Texas Coronary Atherosclerosis Prevention Study.
    Downs JR; Clearfield M; Weis S; Whitney E; Shapiro DR; Beere PA; Langendorfer A; Stein EA; Kruyer W; Gotto AM
    JAMA; 1998 May; 279(20):1615-22. PubMed ID: 9613910
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.